Location History:
- Kanagawa, JP (2020)
- Ashigarakami-gun, JP (2018 - 2023)
Company Filing History:
Years Active: 2018-2023
Title: The Innovations of Kohei Ono: A Pioneer in Liposome Technology
Introduction
Kohei Ono, an esteemed inventor hailing from Ashigarakami-gun, Japan, has made significant contributions to the field of drug delivery systems. With a total of six patents to his name, Ono has focused on innovative solutions that enhance the stability and efficacy of liposome compositions for pharmaceutical applications.
Latest Patents
Ono's most recent invention revolves around a novel liposome composition and method for its production. This invention addresses the need for long-term stability in liposome formulations, achieving a controlled release rate for drugs over extended periods. Specifically, the liposome composition consists of liposomes that contain an inner hyper-osmotic water phase and an outer aqueous solution, where cholesterols are present in the range of 10 mol % to 35 mol % of the total lipid components. Each liposome encapsulates a drug in a dissolved state, enhancing its therapeutic potential.
Career Highlights
Throughout his career, Kohei Ono has worked with Fujifilm Corporation, where he has leveraged his expertise in innovative drug delivery technologies. His commitment to research and development has led to groundbreaking advancements in liposome formulations, which are critical for improving drug bioavailability and patient outcomes.
Collaborations
Ono has collaborated with esteemed colleagues, including Makoto Ono and Takeshi Matsumoto. These partnerships have fostered a dynamic environment for innovation, enabling them to share insights and drive forward the development of effective pharmaceutical formulations.
Conclusion
In conclusion, Kohei Ono stands out as a notable inventor whose work in liposome technology has the potential to revolutionize drug delivery methods. With his latest patents paving the way for improved drug stability and release, Ono is set to make a lasting impact in the pharmaceutical industry. His dedication to innovation, backed by fruitful collaborations, will undoubtedly continue to inspire future advancements in the field.